← Back to Search

Transcranial Magnetic Stimulation

Active dTMS for Alcoholism

N/A
Waitlist Available
Led By Timothy Durazzo, PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial will study whether a treatment called deep transcranial magnetic stimulation (dTMS) is effective for Veterans with AUD.

Eligible Conditions
  • Alcoholism
  • Transcranial Magnetic Stimulation

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Ethanol
Secondary outcome measures
Change from Baseline in Emotion regulation skills

Trial Design

1Treatment groups
Experimental Treatment
Group I: Active dTMSExperimental Treatment1 Intervention
Participants will receive 30 dTMS treatments, administered 3 times per day over 10 consecutive business days, Each treatment visit will last approximately 30 minutes in total.

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,387 Previous Clinical Trials
17,334,040 Total Patients Enrolled
12 Trials studying Alcoholism
2,252 Patients Enrolled for Alcoholism
VA Palo Alto Health Care SystemFED
87 Previous Clinical Trials
56,853 Total Patients Enrolled
1 Trials studying Alcoholism
9 Patients Enrolled for Alcoholism
Timothy Durazzo, PhDPrincipal InvestigatorStanford University

Media Library

Deep Transcranial Magnetic Stimulation (dTMS) H7 coil (Transcranial Magnetic Stimulation) Clinical Trial Eligibility Overview. Trial Name: NCT04927364 — N/A
Alcoholism Research Study Groups: Active dTMS
Alcoholism Clinical Trial 2023: Deep Transcranial Magnetic Stimulation (dTMS) H7 coil Highlights & Side Effects. Trial Name: NCT04927364 — N/A
Deep Transcranial Magnetic Stimulation (dTMS) H7 coil (Transcranial Magnetic Stimulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04927364 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there presently any availability for prospective test subjects?

"Affirmative. Clinicaltrials.gov's records indicate that this health study commenced recruitment on September 6th 2022 and was last edited on October 24th 2022, aiming to include 10 individuals at one medical facility."

Answered by AI

Is enrollment open to individuals below the age of 80 for this experiment?

"This research endeavour is open to individuals aged 21 and above, but younger than 70."

Answered by AI

How may I become involved in this research endeavor?

"This clinical trial is currently looking to recruit 10 individuals aged between 21 and 70 with dialectical behavior therapy. Applicants must adhere to the following criteria: of any gender identity, race or ethnic origin; in active treatment for an alcohol use disorder at VAPAHCS and Foundations of Recovery; on medication for major depressive disorders, cigarette smoking or other psychiatric conditions as long as they do not lower seizure threshold; abstinent from alcohol and non-prescribed substances for a minimum 7 days prior."

Answered by AI

How many individuals have been enrolled in this clinical trial thus far?

"Right. As per information hosted on clinicaltrials.gov, this experiment is presently in the recruitment phase and was initially published on September 6th 2022 before being updated most recently on October 24th of the same year. The trial requires 10 participants to be sourced from a single medical centre."

Answered by AI
Recent research and studies
~4 spots leftby Apr 2025